Bassel Bou Dargham is a Cincinnati, Ohio based male rheumatologist who is specialized in Rheumatology. Active license number of Bassel Bou Dargham for Rheumatology is 35.150362 in Ohio. Bassel Bou Dargham treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Bassel Bou Dargham speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
3130 Highland Ave, Cincinnati, Ohio, 45219-2399
Phone:
513-584-4503
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1649834383
NPI Enumeration Date:
29 Apr, 2019
NPI Last Update On:
29 Mar, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bassel Bou Dargham are as mentioned below.
License Number
Specialization
State
Status
35.150362
Rheumatologist
Ohio
Primary
Student in an Organized Health Care Education/Training Program
Virginia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 636256, Cincinnati, Ohio
Zip:
45263-6256
Phone Number:
513-585-6200
Fax Number:
513-245-3672
Patients can reach Bassel Bou Dargham at 3130 Highland Ave, Cincinnati, Ohio or can call to book an appointment on 513-584-4503. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.